SCHEMBL25633192

SCHEMBL25633192

CCC(NC(=O)CC(CC(C)C)C(=O)O)C(=O)C(C)C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MME P08473 4/20 0.65
BIRC2 Q13490 1/20 0.40
MMP2 P08253 5/20 0.39
MMP9 P14780 5/20 0.39
MMP8 P22894 4/20 0.39
MMP7 P09237 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MMP12 P39900 1/20 0.39
MMP13 P45452 1/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
ACE P12821 1/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
CPA1 P15085 1/20 0.37
MAPT P10636 1/20 0.35
MMP1 P03956 3/20 0.34
FCER2 P06734 2/20 0.34
MMP3 P08254 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25633002 0.86 MME (0.63) MMEMMP2MMP9MMP8MMP7
SCHEMBL20628537 0.78 MME (0.69) MMEMMP2MMP9MMP8MMP7
SCHEMBL25633190 0.77 MME (0.55) MMEBIRC2MMP2MMP9MMP8
SCHEMBL13857484 0.74 CYP2C9 (0.43) MMP2ALDH1A1MEN1LMNAKMT2A
SCHEMBL8269110 0.72 MME (0.61) MMEBIRC2MMP2MMP9MMP8
SCHEMBL15928856 0.72 MME (0.51) MMEALDH1A1ACEMEN1LMNA
SCHEMBL13857486 0.71 ALDH1A1 (0.41) MMEMMP2ALDH1A1ACELMNA
SCHEMBL13857488 0.71 CTSC (0.34) MMP2ALDH1A1LMNAMMP1MMP3
SCHEMBL19696456 0.70 MME (0.50) MMEBIRC2MMP2MMP9MMP8
SCHEMBL17770755 0.70 MME (0.50) MMEBIRC2MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230173093-A1 CHARGE VARIANT LINKERS SEAGEN INC (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230173093-A1 CHARGE VARIANT LINKERS SSB, UACA, CDA MME 4628/4885BIRC2 2526/4885MMP2 4243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.